Showing results (271-280 of 7,735) with videos related to
Sort By:
Pageof 774
Pharmacological Research|April 12, 2020
The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathwayAhmad Tamaddoni, Elahe Mohammadi, Fatemeh Sedaghat, et al.Pharmacological Research|April 12, 2020
Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical resultsYam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.Pharmacological Research|April 20, 2020
Targeting of endoplasmic reticulum (ER) stress in gliomasMariam Markouli, Dimitrios Strepkos, Athanasios G Papavassiliou, et al.Pharmacological Research|April 28, 2020
Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fissionXinyue Liang, Shuyi Wang, Lifeng Wang, et al.Pharmacological Research|April 18, 2020
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptorYanwei Li, Wei Zhou, Li Yang, et al.Pharmacological Research|May 16, 2021
Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancerPengfei Zhang, Weiwei Tao, Cai Lu, et al.Pharmacological Research|August 17, 2021
Antidiabetic drugs and oxidized low-density lipoprotein: A review of anti-atherosclerotic mechanismsAli Ahmadi, Yunes Panahi, Thomas P Johnston, et al.Pharmacological Research|August 19, 2021
Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimeticsSilvano Paternoster, Peter V Simpson, Elena Kokh, et al.Pharmacological Research|August 23, 2021
Activation of PKM2 metabolically controls fulminant liver injury via restoration of pyruvate and reactivation of CDK1Xiaohui Lv, Honghong Zhou, Kai Hu, et al.Pharmacological Research|May 22, 2021
Advances in targeted therapy for osteosarcoma based on molecular classificationYingqian Chen, Runzhi Liu, Wei Wang, et al.Pageof 774